Amarin Corp Ads (NQ: AMRN )

4.460 USD -0.160 (-3.46%)

Official Closing Price Updated: 7:58 PM EST, Nov 23, 2020 Add to My Watchlist

Price and Volume

Volume	8,325,000
Open	4.540
Bid (Size)	4.500 (96)
Ask (Size)	4.510 (15)
Prev. Close	4.620
Today's Range	4.430 - 4.635
52wk Range	3.360 - 26.12
Shares Outstanding	293,584,140
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China

November 19, 2020

Multiple New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association’s Virtual Scientific Sessions 2020

November 18, 2020

Performance

YTD	-79.28%	-79.28%
1 Month	-8.23%	-8.23%
3 Month	-34.32%	-34.32%
6 Month	-36.47%	-36.47%
1 Year	-78.85%	-78.85%

More News

VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® S

November 13, 2020

Amarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences

November 11, 2020

With Growing Incidence of Brain Cancer The Brain Tumor Drug Market Could Reach $3.4 Billion in 2022

November 17, 2020

With Growing Incidence of Brain Cancer The Brain Tumor Drug Market Could Reach $3.4 Billion in 2022

November 17, 2020

Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update

November 05, 2020

More Comprehensive Diagnostics are Needed as Cases Surge Once More

November 13, 2020

New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at American Heart Association’s Virtual Scientific Sessions 2020

October 29, 2020

ROCE Insights For Amarin Corp

November 20, 2020

5 Biotech Penny Stocks To Watch Before Next Week; 1 Up Over 200%

October 29, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.